Lantheus Holdings Inc
NASDAQ:LNTH

Watchlist Manager
Lantheus Holdings Inc Logo
Lantheus Holdings Inc
NASDAQ:LNTH
Watchlist
Price: 60.88 USD -2.23% Market Closed
Market Cap: 4B USD

Lantheus Holdings Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Lantheus Holdings Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Lantheus Holdings Inc
NASDAQ:LNTH
Net Income (Common)
$167.7m
CAGR 3-Years
16%
CAGR 5-Years
235%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Net Income (Common)
$168.2m
CAGR 3-Years
25%
CAGR 5-Years
10%
CAGR 10-Years
21%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Net Income (Common)
-$882m
CAGR 3-Years
-2%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
ICU Medical Inc
NASDAQ:ICUI
Net Income (Common)
-$7.4m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Income (Common)
$378.6m
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
11%
Merit Medical Systems Inc
NASDAQ:MMSI
Net Income (Common)
$118.4m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
16%
No Stocks Found

Lantheus Holdings Inc
Glance View

Lantheus Holdings Inc. is a captivating player in the healthcare sector, primarily operating within the niche of diagnostic medical imaging. The company's core mission revolves around enhancing diagnosis and treatment pathways, thus playing an integral role in patient care. At the heart of Lantheus's operations are its innovative diagnostic and therapeutic products, including radiopharmaceuticals and contrast agents that physicians rely on to obtain detailed images of the body's organs and tissues. Through a combination of proprietary technologies and strategic partnerships, Lantheus delivers solutions that help medical professionals make more informed clinical decisions, ultimately aiming to improve patient outcomes. This business generates revenue by developing, manufacturing, and commercializing its products, which are utilized across hospitals, clinics, and research centers worldwide. By consistently investing in research and development, Lantheus ensures a competitive edge through a robust pipeline of next-generation imaging agents. Strategic alliances and collaborative ventures further fortify its market presence, allowing the company to expand its reach and integrate new advancements into its product offerings. This commitment to innovation and collaboration has not only cemented its reputation in the life sciences industry but also ensures a steady and growing stream of income from its well-regarded product lines.

LNTH Intrinsic Value
99.78 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Lantheus Holdings Inc's Net Income (Common)?
Net Income (Common)
167.7m USD

Based on the financial report for Sep 30, 2025, Lantheus Holdings Inc's Net Income (Common) amounts to 167.7m USD.

What is Lantheus Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
235%

Over the last year, the Net Income (Common) growth was -61%. The average annual Net Income (Common) growth rates for Lantheus Holdings Inc have been 16% over the past three years , 235% over the past five years .

Back to Top